Want this question answered?
Von Recklinghausen
Neurofibromatosis type 1 (NF1) was first described in 1882 by the German pathologist Von Recklinghausen. Neurofibromatosis type 2 (NF2) was first described in 1820 by the Scottish surgeon JH Wishart.
http://en.wikipedia.org/wiki/Neurofibromatosis
Clinical genetic testing can confirm the presence of a mutation in the neurofibromatosis type 1 (NF1) gene. Prenatal testing for NF1 mutations is also possible using amniocentesis or chorionic villus sampling procedures. Genetic testing for neurofibromatosis type 2 (NF2) mutations is sometimes available but is accurate only in about 65 percent of those individuals tested.
There are no available treatments for the disorders which underlie either type of neurofibromatosis. To some extent, the symptoms of NF-1 and NF-2 can be treated individually. Skin tumors can be surgically removed. Some brain tumors.
Neurofibromatosis is usually diagnosed when the patient has 10 or more cafe-au-lait spots.
Yes, in Dallas, Texas it is called the NSG (Neurofibromatosis Support Group)
The dominant theory throughout much of the 20th century was that Merrick suffered from neurofibromatosis type I. In 1986, a new theory emerged that he had Proteus syndrome. In 2001 it was proposed that Merrick had suffered from a combination of neurofibromatosis type I and Proteus syndrome. DNA tests conducted on his hair and bones have proven inconclusive.
I found this useful link http://www.ninds.nih.gov/disorders/neurofibromatosis/neurofibromatosis.htm
The dominant theory throughout much of the 20th century was that Merrick suffered from neurofibromatosis type I. In 1986, a new theory emerged that he had Proteus syndrome. In 2001 it was proposed that Merrick had suffered from a combination of neurofibromatosis type I and Proteus syndrome. DNA tests conducted on his hair and bones have proven inconclusive.
Depending on context, NF-3 could be neurofibromatosis type 3 or Nitrogen trifluouride.
hereditary condition associated with an increased risk of bilateral acoustic neuromas, other nerve cell tumors and cataracts.